FibroGen (FGEN) Reports Q1 Loss of $0.53/Share

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.53), versus ($0.50) reported last year. Revenue for the quarter came in at $22.86 million, versus $31.93 million reported last year.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Lucid reports Q2 output, names new CFO and five other leaders
• Tesla Q2 deliveries crush forecasts at 480,126, erasing backlog concerns